Arrowhead (ARWR) Hits 3-Year High on Strong Earnings, FDA Approval
Arrowhead Pharmaceuticals soared to a new three-year high on Wednesday, as investors took heart from its impressive earnings performance for the full fiscal year, alongside the Food and Drug Administration...






